KEY PRODUCTS
Veranova: A CDMO that manages complexity with confidence.
01 1Veranova
01 1LENALIDOMIDE
01 1U.S.A
01 1Active
01 1Complete
Veranova: A CDMO that manages complexity with confidence.
GDUFA
DMF Review : Complete
Rev. Date : 2022-07-26
Pay. Date : 2022-05-10
DMF Number : 36810
Submission : 2022-05-12
Status : Active
Type : II
20
Veranova Lp, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Veranova: A CDMO that manages complexity with confidence.
One of their notable products is LENALIDOMIDE, with a corresponding US DMF Number 36810.
Remarkably, this DMF maintains an Active status since its submission on May 12, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 26, 2022, and payment made on May 10, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
